MENU
ABVX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Abivax SA (ABVX) Earnings Date & Reports
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more
A.I. Advisor
published Earnings
ABVX is expected to report earnings to fall 25.73% to -126 cents per share on December 21
Q3'26
Est.
$-1.27
Q2'26
Missed
by $0.63
Q1'26
Missed
by $0.10
Q4'25
Missed
by $0.54
Q3'25
Missed
by $1.79
The last earnings report on September 21 showed earnings per share of -171 cents, missing the estimate of -108 cents. With 410.11K shares outstanding, the current market capitalization sits at 7.48B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
7-11 boulevard Haussmann
Phone
+33 153830963
Employees
69
Web
https://www.abivax.com